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Introduction: Hepatopulmonary syndrome is a clinical syndrome that can affect patients of all ages with liver disease
and is more common in children with biliary atresia. Contrast echocardiography is the test of choice to diagnose
the presence of intrapulmonary vascular dilatation. The established treatment for hepatopulmonary syndrome is
liver transplantation.
Case presentation: We present the case of an 8-month-old Caucasian baby boy with a history of biliary atresia,
polysplenia, and interrupted inferior vena cava who presented with hypoxemia and cyanosis that progressed
rapidly. A chest computed tomography angiogram revealed significant dilatation of the pulmonary vasculature,
prompting further evaluation and diagnosis of hepatopulmonary syndrome with contrast echocardiography. He
was maintained on a milrinone infusion while awaiting liver transplantation. His hypoxemia improved slowly
following liver transplantation, requiring tracheostomy and prolonged ventilator dependence.
Conclusions: Hepatopulmonary syndrome should be included in the differential for progressive hypoxemia in
children with liver disease, particularly those with biliary atresia. Imaging with chest computed tomography
angiogram and contrast echocardiography should be considered in cases of unexplained refractory hypoxemia.
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Hepatopulmonary syndrome (HPS) is a rare condition in
children, although it is more common in children with a
history of biliary atresia [1,2]. HPS is identified by the
presence of liver disease and intrapulmonary vascular dila-
tation (IPVD) resulting in impaired oxygenation. Clinical
manifestations of HPS are related to both liver and pul-
monary disease and include spider nevi, clubbing, dys-
pnea, and cyanosis [3].
Currently, the only proven treatment for HPS is ortho-
topic liver transplantation (OLT), and HPS is considered
a relative indication for transplantation [4]. In fact, be-
cause HPS may present in the absence of synthetic liver
dysfunction, it may be the basis for requesting a petition
of exception from the United Network for Organ Sharing
(UNOS). Here, we describe a case of a baby with hetero-
taxy syndrome and biliary atresia who presented with* Correspondence: morgenlf@med.umich.edu
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unless otherwise stated.progressive hypoxemia. The diagnosis of HPS was sug-
gested based on findings noted on a chest computed
tomography (CT) angiogram. The baby was maintained
on a therapeutic regimen including a milrinone infusion
until OLT could be performed, after which his hypox-
emia gradually resolved. To the best of our knowledge,
the use of milrinone in a pediatric patient with HPS has
not been previously described. The diagnosis, manage-
ment, and outcomes associated with HPS are reviewed.
Case presentation
An 8-month-old Caucasian baby boy with heterotaxy syn-
drome was admitted to our general pediatric ward after
presenting to a scheduled clinic visit with fever, hypox-
emia and cyanosis. His history was significant for dextro-
cardia, polysplenia, interrupted inferior vena cava, biliary
atresia status post-Kasai procedure, and malrotation status
post-Ladd’s procedure. He was febrile on presentation,
and was started on oxygen via nasal cannula for oxyhemo-
globin saturations as low as 70%. His chest radiograph on
admission showed a patchy right lower lobe opacity, and he
was started on antibiotics out of concern for pneumonia.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Axial computed tomography angiography images
using intravenous contrast material in an 8-month-old baby
boy below the level of carina (A) towards the base (B, C).
Diffuse dilatation of the pulmonary vasculature is seen to be more
prominent in caudal sections (B, C). Lung parenchyma is normal
and dextrocardia is seen.
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care unit (PICU) for refractory hypoxemia requiring high
flow oxygen therapy.
Throughout his PICU admission, he continued to re-
quire high flow oxygen up to 9L per minute and fraction
of inspired oxygen (FiO2) of 1 to maintain oxyhemoglobin
saturation greater than 75%, with persistent desaturations
while upset. Early in his admission, he developed increased
work of breathing requiring positive pressure ventilation
with bilevel positive airway pressure. A chest radio-
graph revealed pulmonary edema, and brain natriuretic
peptide (BNP) at that time was elevated at 1130pg/mL.
His pulmonary edema improved with diuresis, result-
ing in de-escalation of therapy with return to standard
nasal cannula. He required blood pressure support with a
dopamine infusion during aggressive diuresis, which was
subsequently weaned off without complication. Multiple
echocardiograms revealed no clear cardiac etiology of his
hypoxemia.
A chest CT angiogram with high resolution recon-
struction of the lung parenchyma was performed on the
recommendation of our Radiology department to further
evaluate the pulmonary vasculature and lung paren-
chyma. CT imaging showed dilatation of the pulmonary
vasculature bilaterally without significant abnormalities
of the lung parenchyma (Figure 1). Pulmonary arterial
hypertension was felt to be an unlikely cause of his dilated
pulmonary vasculature as right ventricular pressures were
measured as less than half of systemic pressures on echo-
cardiogram. Given his history of biliary atresia and constel-
lation of symptoms, HPS was included on the differential
diagnosis. He underwent agitated saline contrast study,
which showed bubbles entering the right-sided atrium
(systemic atrium in the setting of dextrocardia) through
a right pulmonary vein approximately 3 cardiac beats after
opacification of the left-sided chambers (Figure 2), consist-
ent with clinically significant intrapulmonary shunting.
Abdominal magnetic resonance imaging (MRI) was per-
formed to evaluate for the presence of a congenital porto-
systemic shunt given the strong association of Abernethy
malformation and heterotaxy syndrome and the possibility
of reversal of HPS with shunt occlusion. MRI did not re-
veal portosystemic shunting. The patient subsequently
underwent evaluation for liver transplantation. His liver
enzymes and coagulation studies were normal. His biliru-
bin levels were also normal and given normal bile ducts
on abdominal ultrasound, a hepatobiliary iminodiacetic
acid scan was not performed. Abdominal ultrasound also
demonstrated diffuse liver disease, patent portal vein with
hepatopetal flow, and no ascites. He did have polysplenia
with splenomegaly. He had no signs of collateral circula-
tion on examination. No abnormalities were noted in his
stools. His partial pressure of oxygen in arterial blood
(PaO2) was measured at 29mmHg while on FiO2 of 0.5.
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Figure 2 Off-axis apical view with contrast injection (agitated
saline). Patient has dextrocardia (A). Note good opacification of the
right atrium and right ventricle in (B) with contrast. No contrast is
seen initially in the left atrium, suggesting no atrial level shunt.
Bubbles were seen in the left atrium after several beats (C) suggesting
intrapulmonary shunts or arteriovenous malformations rather
than intracardiac shunts (images courtesy of Jimmy C Lu MD).
Abbreviations: LA, left atrium; LV, left ventricle; RA, right atrium;
RV, right ventricle.
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liver disease score of 28, which was further increased to
35 following petition to UNOS for worsening clinical
status.
Prior to diagnosis of HPS, the patient was initiated on
a milrinone infusion for suspicion of diastolic heart fail-
ure. Following the diagnosis, he was trialed off milrinone
with the rationale that further pulmonary vasodilation
actually may be deleterious given the diagnosis of HPS.
However, he responded poorly with subsequent oxy-
hemoglobin desaturations requiring reinitiation of the
infusion. His oxygenation stabilized on a milrinone infu-
sion of 0.5μg/kg/minute. Inhaled nitric oxide was also
trialed without significant improvement in oxygen re-
quirement and was subsequently weaned off. Oxygen
requirements ultimately stabilized on a diuretic regimen
including spironolactone and furosemide.
He underwent OLT 2 months after initial presentation.
His postoperative period was complicated by hypercarbic
and hypoxemic respiratory failure requiring mechanical
ventilation. He underwent tracheostomy for chronic
ventilator-dependent respiratory failure. He was trans-
ferred out of the PICU 2 months after OLT and subse-
quently weaned off mechanical ventilation during the
daytime. He was discharged home 4 months following
OLT on FiO2 of 0.21 through a tracheostomy mask
with nighttime ventilator support. He continues to do
well. Please see Figure 3 for a timeline of the patient’s
clinical course.
Discussion
This case report of HPS highlights the importance of
considering HPS in patients with liver disease and other-
wise unexplained hypoxemia, even without significant
liver dysfunction. It also highlights the diagnostic modal-
ities used to diagnose HPS in pediatric patients including
CT angiogram and contrast echocardiography. Given the
pathophysiology of HPS involving pulmonary vascular
dilatation, therapies such as milrinone and nitric oxide
may appear counterintuitive. This is a limitation of our
approach as it is unclear why our patient had such a sig-
nificant response to milrinone, although we speculate
there may have been a component of diastolic heart fail-
ure given the elevated BNP level.
The clinical diagnosis of HPS is based upon the triad
of IPVD, liver disease, and impaired oxygenation, defined
as partial pressure of oxygen <80mmHg or an alveolar-
arterial oxygen gradient greater than 15mmHg when
breathing room air [5]. HPS is a rare condition that can
affect patients of all ages. The patient in this case is not-
able for his young age; however, HPS has been diagnosed
in children as young as 6 months [1]. It is associated with
biliary atresia and polysplenia, and the reported preva-
lence of HPS in children with liver disease has ranged
Diagnosed with biliary atresia 
(6 weeks old)




Admitted for respiratory distress 
and hypoxemia (8 months old)
Day 216
Transferred to PICU for 
escalating ventilatory support
Day 217







Discharged home from hospital 
(14 months old)
Day 387
Figure 3 Timeline of the patient’s clinical course. Abbreviations:
HPS, hepatopulmonary syndrome; OLT, orthotopic liver transplantation;
PICU, pediatric intensive care unit.
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to 20% in those with biliary atresia [1,2].
Common presenting signs and symptoms of HPS include
dyspnea, cyanosis and hypoxemia, which may worsen with
crying and exertion. Platypnea (dyspnea that worsens in
the upright position compared to supine) and orthodeoxia
(decrease in PaO2 >5% or 4mmHg in the upright position)
are characteristic findings in HPS, and may be related to
increased pulmonary shunting in the context of altered
pulmonary vascular tone [6]. Of importance, HPS may be
the cause of otherwise unexplained hypoxemia in a patientwith acute or chronic liver disease, as was seen in this
case. Other signs and symptoms of HPS are related to
liver disease, such as spider nevi, palmar erythema, and
thenar atrophy [3]. Spider nevi are cutaneous vascular
lesions that have been associated with more severe hyp-
oxemia and pulmonary dilatation and have thus been
proposed as a cutaneous marker for IPVD [7].
With regard to abnormalities in the results of labora-
tory tests, elevated BNP has been found in children with
intrapulmonary vascular shunting, which is hypothesized
to reflect the increased left atrial volume in patients with
IPVD [8]. Of interest, the presence of intrapulmonary
shunting is not associated with the severity of liver dis-
ease, as was demonstrated in this patient who had HPS
in the absence of synthetic liver dysfunction [9].
From a radiological standpoint, HPS is characterized
by diffuse dilatation of the peripheral pulmonary vascula-
ture. In this case, the diagnosis of HPS was first discussed
following the findings of dilated pulmonary vasculature on
CT angiogram. Thus, CT angiogram can be helpful in a
patient with liver disease and unexplained hypoxemia.
Subsequent testing via contrast-enhanced transthoracic
echocardiography with agitated saline is useful in de-
tecting the presence of IPVD. During this procedure, sa-
line is shaken to produce microbubbles greater than
10μm in diameter and administered through a periph-
eral vein in the arm. The presence of microbubble opa-
cification in the left atrium within 3 to 6 cardiac cycles
following opacification of the right atrium is considered
a positive test for the presence of intrapulmonary vascu-
lar shunting [5]. In consequence, contrast echocardiog-
raphy is the recommended study for the evaluation of
IPVD in diagnosing HPS, as it is more sensitive than the
lung perfusion scan with technetium and has no radi-
ation exposure.
Of note, it is important to exclude a congenital extra-
hepatic portosystemic shunt (Abernethy malformation)
in children with HPS, especially in patients with hetero-
taxy syndrome, as this will impact the management of
the patient. In the presence of a portosystemic shunt,
HPS may reverse with shunt occlusion if the portal vein
is patent. If an extrahepatic portosystemic shunt has
been missed, hypoxemia may return after the initial re-
sponse to liver transplantation [10].
At this time, there are no proven pharmacological
treatments for HPS, although there are case reports of
improvement with therapies aimed at inhibiting nitric
oxide [11]. Pentoxifylline (PTX), a phosphodiesterase in-
hibitor, is one such therapy that has been used in studies
for the treatment of HPS. The potential of PTX in HPS
has been attributed in part to its inhibitory effect on ni-
tric oxide synthase resulting in decreased production of
nitric oxide. PTX has also been found to down regulate
angiogenesis [11]. In a study performed by Kianifar et al.,
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oxygen pressure, oxyhemoglobin saturation, and de-
creased alveolar-arterial oxygen gradient following 3
months of treatment with PTX [12]. Milrinone is a se-
lective phosphodiesterase 3 inhibitor with positive ino-
tropic and vasodilatory effects. Although implemented
as a bridge in our patient with some success, the use of
milrinone has not been well studied in HPS. Nonetheless,
milrinone has been used as rescue therapy for portopul-
monary hypertension at the time of OLT [13].
Liver transplantation remains the only established ther-
apy for HPS. Several studies have shown the reversibility
of HPS in the majority of pediatric patients following OLT
[2]. Post-transplantation survival has been found to be
lower in patients with HPS compared to overall post-OLT
survival, with 1-year post-transplantation survival ranging
from 62% to 84% in patients with HPS compared to 90%
to 92% in patients without HPS [9,14]. Specifically in
pediatric patients with HPS, the 1-year survival following
OLT ranges from 62% to 100% [2,15]. Gupta et al. found
no significant difference in post-transplantation survival
between pediatric patients with and without HPS; however,
all patients with HPS in the study had PaO2 >50mmHg
[2]. It should be noted that preoperative hypoxemia is
an important prognosticator for both postoperative
mortality and time to resolution of hypoxemia following
transplant in HPS [14,15]. Hypoxemia may transiently
worsen postoperatively, requiring prolonged support
with mechanical ventilation for up to several months
following transplant. The patient in this case was se-
verely hypoxemic preoperatively and exhibited pro-
longed ventilator dependence after OLT.
Conclusions
In summary, HPS is characterized by progressive hypox-
emia caused by intrapulmonary shunting in patients with
liver disease. While it is a rare condition in the general
population, it is not uncommon in patients with biliary
atresia, and should thus be included in the differential
diagnosis of hypoxemia in children with biliary atresia,
even without evidence of synthetic liver dysfunction. Saline
contrast echocardiogram and CT angiogram may be useful
studies in such patients and typically reveal extracardiac
shunt and pulmonary vascular dilatation in those with
HPS. Full resolution of HPS is possible with liver trans-
plantation, and the severity of hypoxemia is associated
with higher postoperative mortality. Therefore, the diagno-
sis of HPS should ideally be made as early as possible.
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